The LCHN Antibody (PACO63335) is a highly specific polyclonal antibody designed for researchers studying LCHN, a protein involved in immune regulation and cell signaling pathways. This antibody, raised in rabbits, is optimized for use in Western blot applications and is highly reactive with human samples.LCHN, also known as immune regulatory molecule, is a key player in modulating immune responses and has been implicated in various diseases, including cancers and autoimmune disorders. By targeting LCHN with this antibody, researchers can gain valuable insights into its role in immune regulation and its potential as a therapeutic target.
This antibody is suitable for a wide range of applications, including immunohistochemistry, ELISA, and flow cytometry, making it a versatile tool for studying the function and regulation of LCHN in different cell types and disease contexts. Researchers in immunology, cancer biology, and autoimmune research will find this antibody invaluable for their studies into immune regulation and disease mechanisms.
Western Blot. Positive WB detected in: HL60 whole cell lysate. All lanes: LCHN antibody at 1:1000. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 52 kDa. Observed band size: 52 kDa.
IHC image of PACO63335 diluted at 1:100 and staining in paraffin-embedded human colon cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
Background:
May play a role in neuritogenesis, as well as in neuronal recovery and/or restructuring in the hippocampus following transient cerebral ischemia.
